•
Dec 31, 2024
Merit Medical Q4 2024 Earnings Report
Merit Medical Q4 2024 Earnings Report
Key Takeaways
Merit Medical reported revenue of $355.2 million for Q4 2024, up 9.4% year-over-year, with GAAP EPS of $0.46 and non-GAAP EPS of $0.93. The company achieved strong performance in revenue and profitability, supported by organic growth and acquisitions.
Revenue increased to $355.2 million, up 9.4% year-over-year.
GAAP EPS was $0.46, down 2.6% year-over-year.
Non-GAAP EPS improved to $0.93, up 25.8%.
Free cash flow generation was $65.3 million, up 18.4%.
Merit Medical
Merit Medical
Merit Medical Revenue by Segment
Forward Guidance
Merit Medical expects continued revenue and profitability growth in FY 2025, driven by strong performance across key segments and ongoing strategic initiatives.
Positive Outlook
- Projected revenue growth of 8% - 10% year-over-year.
- Non-GAAP EPS guidance range of $3.58 to $3.70.
- Continued investment in growth initiatives.
- Focus on operational efficiency improvements.
- Strong pipeline of innovative medical solutions.
Challenges Ahead
- Potential impact of foreign currency fluctuations.
- Rising costs of raw materials.
- Ongoing regulatory compliance requirements.
- Competitive pressures in key markets.
- Potential macroeconomic uncertainties.
Revenue & Expenses
Visualization of income flow from segment revenue to net income